C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2002
11/14/2002	US20020168710 Anticancer agents; cardiovascular disorders; anticholesterol agents
11/14/2002	US20020168708 Nucleotide sequences coding polypeptide for use in the treatment of parkinson's, chronic obstructive airways, irritable bowel syndrome, muscle and urogenital disorders
11/14/2002	US20020168702 Isolating cells expressing secreted proteins
11/14/2002	US20020168690 Peptide for use in the treatment of arthritis
11/14/2002	US20020168689 Detecting nervous system disorders in animals; obtain tissue sample, incubate with antibody, detect bound antibody, determine concentration of bound antibody
11/14/2002	US20020168684 Generating preferential immunoglobulins; obtain peptide library, immunize cells, isolate anitgen, purify immunoglobulin
11/14/2002	US20020168683 Human pellino polypeptides
11/14/2002	US20020168679 Staining agents and protocols for characterizing malignant cells in culture
11/14/2002	US20020168672 Nucleotide sequences coding proteins for use in the treatment of tumors
11/14/2002	US20020168650 Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
11/14/2002	US20020168635 Nucleotide sequences coding polypeptides for use in screening modulators of taste
11/14/2002	US20020168629 Ligand capture-directed selection of antibody
11/14/2002	US20020168628 Variant of LAV viruses
11/14/2002	US20020168379 Veterinary medicine; swine respiratory system disorders
11/14/2002	US20020168376 Plant extracts; sensitization of an animal; screening
11/14/2002	US20020168375 Biosynthetic binding proteins for immuno-targeting
11/14/2002	US20020168371 Process for reducing antibody response against xenografts
11/14/2002	US20020168368 Antibody-conjugated antibodies
11/14/2002	US20020168367 Novel immunoadhesins for treating and preventing viral and bacterial diseases
11/14/2002	US20020168366 Administering a binding agent capable of binding platelets binding platelets to the binding agent to form captured platelets, inducing activation of the captured platelets and forming a thrombus, which provides therapeutic benefit
11/14/2002	US20020168364 Methods and compositions for modulating tumor growth
11/14/2002	US20020168362 Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
11/14/2002	US20020168361 An isolated protein comprising a soluble CD97 alpha subunit, and soluble subunit is selected from the group alpha 1, alpha 2, and alpha 3, originate as proprotein with beta subunit
11/14/2002	US20020168360 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphanubeta3 antagonists in combination with other prophylactic or therapeutic agents
11/14/2002	US20020168357 Administering to a mammal an antibody capable of binding native tissue factor, and linked covalently to a cell antigen or an effector molecule to provide complement fixing ability and antibody dependent cell mediated cytotoxicity
11/14/2002	US20020168356 An antibody capable of binding a PF4AR (platelet factor 4 superfamily member) polypeptide and the polypeptide is an interleukin-8 receptor; antiinflammatory agent
11/14/2002	US20020168348 Prolonging the acceptance of a graft by administering a short course of an immunosuppressant
11/14/2002	US20020168343 Combines transductional targeting via binding to angiotensin converting enzyme expressed on pulmonary endothelial cells with transcriptional targeting using vascular endothelial growth factor type 1 receptor promoter
11/14/2002	US20020168339 Biological material for treating a mammal by antibody gene transfer and pharmaceutical composition containing same
11/14/2002	CA2449166A1 Combination therapy using anti-egfr antibodies and anti-hormonal agents
11/14/2002	CA2447386A1 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
11/14/2002	CA2446857A1 Reproductive cancer diagnosis and therapy
11/14/2002	CA2446838A1 Novel mutation
11/14/2002	CA2446788A1 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002	CA2446666A1 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
11/14/2002	CA2446640A1 .beta.-amyloid peptide-binding proteins and polynucleotides encoding the same
11/14/2002	CA2446480A1 Method of preventing cell death using antibodies to neural thread proteins
11/14/2002	CA2446458A1 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	CA2446437A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	CA2446294A1 Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them
11/14/2002	CA2446087A1 Recombinant tumor specific antibody and use thereof
11/14/2002	CA2445989A1 Colon cancer antigen panel
11/14/2002	CA2445269A1 Anti-ige antibody to treat ocular allergies
11/14/2002	CA2438978A1 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
11/14/2002	CA2435142A1 Kinases and phosphatases
11/13/2002	EP1256348A1 Remedies for hepatitis c
11/13/2002	EP1255993A2 Methods for identifying modulators for balance related disorders
11/13/2002	EP1255864A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255859A2 Tissue specific genes of diagnostic import
11/13/2002	EP1255857A2 Method of identifying toxic agents using differential gene expression
11/13/2002	EP1255845A2 Modified cytokines for use in cancer therapy
11/13/2002	EP1255844A1 Humanized anti-ccr2 antibodies and methods of use therefor
11/13/2002	EP1255842A1 Larynx carcinoma-associated protein larcap-1
11/13/2002	EP1255837A2 Il-17 like molecules and uses thereof
11/13/2002	EP1255835A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255833A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255831A2 Sperm specific proteins
11/13/2002	EP1255830A2 Cbp86, a sperm specific protein
11/13/2002	EP1255829A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
11/13/2002	EP1255824A2 Non-human transgenic animals for the study of neurodegenerative syndromes
11/13/2002	EP1255819A2 Human kinases
11/13/2002	EP1255817A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255781A1 Antibody binding superficial zone protein and their uses in diagnosis and screening methods
11/13/2002	EP1255780A1 Methods and compositions for generating human monoclonal antibodies
11/13/2002	EP1255778A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255777A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255776A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255768A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255767A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255766A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255562A2 Use of opri lipoprotein from pseudomonas as a th1 inducing natural adjuvant for heterologous antigens
11/13/2002	EP1255558A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules
11/13/2002	EP1084146B1 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof
11/13/2002	EP1012162B1 Soluble proteins
11/13/2002	EP0843557B1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
11/13/2002	EP0836482B1 Subunit vaccine against flavivirus infection
11/13/2002	EP0738281B1 Peptides and their uses against psoriasis
11/13/2002	EP0697889B1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY
11/13/2002	EP0449958B2 Meningococcal class 1 outer-membrane protein vaccine
11/13/2002	CN1379858A Specific autoimmunity reaction against isomerization/optical reverse antigenic determinant; application in autoimmunity disease diagnosis
11/13/2002	CN1379817A Composition and methods for increasing cholesterol efflux and raising HDL using ATP binding cassettte ttansporter protein ABC1
11/13/2002	CN1379816A Human G-protein coupled receptor
11/13/2002	CN1379815A BAFF receptor (BCMA), immunoregulatory agent
11/13/2002	CN1379782A Subunit optimized fusion proteins
11/13/2002	CN1379685A Novel method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and beta integrins
11/13/2002	CN1379684A Treating prostate cancer with anti-ErbB2 antibodies
11/13/2002	CN1379092A Human cyclophilin coding sequence and its preparing process and application
11/12/2002	US6479642 Cortistatin: neuropeptides
11/12/2002	US6479641 Amino acid sequences for use in the detection and separation of preferential microorganism from samples
11/12/2002	US6479639 Monoclonal antibody to a human MDR1 multidrug resistance gene product and uses
11/12/2002	US6479635 Receptor activator of NF-κB
11/12/2002	US6479633 Chemokine alpha 2
11/12/2002	US6479632 Tumor necrosis factor inhibitory protein and its purification
11/12/2002	US6479630 Human purinergic P2U receptor
11/12/2002	US6479628 Methods and materials relating to IMPDH and GMP production
11/12/2002	US6479459 Cytokine designated lerk-5
11/12/2002	US6479284 Humanized antibody and uses thereof
11/12/2002	US6479280 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
11/12/2002	US6479274 DNA molecules encoding human HELA2 or testisin serine proteinases
11/12/2002	US6479270 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof

1 ... 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 ... 1494